BamSEC and AlphaSense Join Forces
Learn More

Maze Therapeutics Inc. – Material Contracts

NASDAQ: MAZE    
Share price (7/22/26): $28.49    
Market cap (7/22/26): $1.577 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.19
from 10-K 96 pages Agreement
12/34/56
EX-10.3
from 10-Q 5 pages July 11, 2025 Misbah Tahir Sent via Email Re: Employment With Maze Therapeutics Inc. Dear Misbah
12/34/56
EX-10.2
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.16
from S-1/A 3 pages January 7, 2025 Courtney Phillips Sent via Email Re: Continued Employment With Maze Therapeutics Inc. Dear Courtney
12/34/56
EX-10.13
from S-1/A 4 pages January 7, 2025 Harold Bernstein Sent via Email Re: Continued Employment With Maze Therapeutics Inc. Dear Harold
12/34/56
EX-10.12
from S-1/A 4 pages January 21, 2025 Jason Coloma Sent via Email Re: Continued Employment With Maze Therapeutics Inc. Dear Jason
12/34/56
EX-10.11
from S-1/A 2 pages Maze Therapeutics, Inc. (“Company”) Non-Employee Director Compensation Policy Effective January [ ], 2025
12/34/56
EX-10.5
from S-1/A 20 pages Maze Therapeutics, Inc. 2025 Employee Stock Purchase Plan
12/34/56
EX-10.4
from S-1/A 71 pages Maze Therapeutics, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.15
from S-1 10 pages Maze Therapeutics, Inc. Amended and Restated Executive Severance and Change in Control Plan
12/34/56
EX-10.14
from S-1 3 pages [Date] [Name] Sent via Email Re: Continued Employment With Maze Therapeutics Inc. Dear [Name]
12/34/56
EX-10.11
from S-1 2 pages Maze Therapeutics, Inc. (“Company”) Non-Employee Director Compensation Policy Effective January [ ], 2025
12/34/56
EX-10.10
from S-1 75 pages License Agreement
12/34/56
EX-10.8
from S-1 10 pages Maze Therapeutics, Inc. Advisor Agreement
12/34/56
EX-10.7
from S-1 9 pages Consulting Agreement
12/34/56
EX-10.6
from S-1 92 pages The Cove at Oyster Point Lease
12/34/56
EX-10.5
from S-1 20 pages Maze Therapeutics, Inc. 2025 Employee Stock Purchase Plan
12/34/56
EX-10.4
from S-1 71 pages Maze Therapeutics, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.3
from S-1 67 pages Maze Therapeutics, Inc. 2019 Equity Incentive Plan as Adopted on August 22, 2019
12/34/56